Justices grant four new cases, including Chevron companion case

Justices grant four new cases, including <em>Chevron</em> companion case

Share

The Supreme Court has added a second case asking it to overrule its landmark 1984 decision in Chevron v. Natural Resources Defense Council to its docket for the 2023-24 term. The announcement came on a list of orders released on Friday afternoon from the justices’ private conference earlier in the day. The court will hear oral argument in both Relentless v. Department of Commerce, the case granted on Friday, and Loper Bright Enterprises v. Raimondo, which it agreed in … Read the rest

EU Pharma Legislation Review Series: National MA Procedures Including the Mutual Recognition Procedure and Decentralized Procedure

The European Commission (the “Commission”) wants to “avoid unnecessary administrative and financial burdens for applicants and competent authorities.”  As such, the Commission’s proposal for a revised Directive on the Union Code Relating to Medicinal Products for Human Use (the “Directive”) retains the Decentralized Procedure (“DCP”) and Mutual Recognition Procedure (“MRP”).  Chapter III of the Directive sets out the new procedures for national marketing authorizations (“MAs”).  This includes a purely national MA procedure granted in a single Member State … Read the rest

Court grants review in new batch of cases, including dispute on religious rights of employees

Court grants review in new batch of cases, including dispute on religious rights of employees

Share

The Supreme Court will review how employers must accommodate their employees’ religious practices, how courts should decide whether threatening statements are protected by the First Amendment, and whether a local government violated the Constitution when it confiscated and sold a $ 40,000 home based on the owner’s failure to pay $ 15,000 in property taxes.

Those issues are among a slew of new disputes that the justices added to their docket on Friday afternoon in an order list from … Read the rest

Warnings about honey with ingredients that are not disclosed, including ED drugs

The U.S. Food and Drug Administration on Tuesday issued warning letters to four companies for illegally selling honey-based products that may pose a significant health risk to consumers.

The FDA’s laboratory testing found that product samples contained active drug ingredients not listed on the product labels, including the active drug ingredients found in Cialis (tadalafil) and Viagra (sildenafil), which are FDA approved prescription drugs used to treat men with erectile dysfunction (ED).

Sildenafil and tadalafil are restricted to use under … Read the rest

Recent FTC Settlement Highlights Agency’s Focus on Children’s Privacy & Use of Disgorgement Remedy Including in AI Context

As readers of CPW know, the Federal Trade Commission (“FTC”) has made it clear that privacy and security will be top-of-mind issues for the Commission for the foreseeable future. Recently, the FTC announced its settlement with WW International, Inc.—formerly known as Weight Watchers (“Weight Watchers”)—over claims the company violated the Children’s Online Privacy Protection Act (“COPPA”) by collecting children’s personal information without providing notice or obtaining parental consent.

The settlement requires the company to pay a $ 1.5 million penalty, … Read the rest